Chapter 7 Clinical peptidomics: peptide-biomarker discovery in blood

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Comprehensive Analytical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0166-526X(05)46007-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Peptidomics: the comprehensive analysis of peptides in complex biological mixtures.

  2012cited by this paper
• Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display

  2005cited by this paper
• Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study

  2005cited by this paper
• Correlation‐associated peptide networks of human cerebrospinal fluid

  2005cited by this paper
• Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool

  2004cited by this paper
• Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS.

  2004cited by this paper
• Impaired glucose tolerance and impaired fasting glucose.

  2004cited by this paper
• The use of proteomics for the assessment of clinical samples in research.

  2004cited by this paper
• The Human Plasma Proteome

  2004cited by this paper
• How Industry Is Approaching the Search for New Diagnostic Markers and Biomarkers*

  2004cited by this paper
• How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer.

  2004cited by this paper
• National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report.

  2004cited by this paper
• Advancement of Biomarker Discovery and Validation through the HUPO Plasma Proteome Project

  2004cited by this paper
• Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry.

  2004cited by this paper
• The Human Proteome Organization Plasma Proteome Project pilot phase: Reference specimens, technology platform comparisons, and standardized data submissions and analyses

  2004cited by this paper
• Role of β-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Polypeptide

  2004cited by this paper
• Decision tree classification of proteins identified by mass spectrometry of blood serum samples from people with and without lung cancer

  2003cited by this paper
• Generalizable mass spectrometry mining used to identify disease state biomarkers from blood serum

  2003cited by this paper
• Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

  2003cited by this paper
• Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV.

  2003cited by this paper
• Mass spectrometry-based clinical proteomics.

  2003cited by this paper
• Clinical biomarkers in drug discovery and development

  2003cited by this paper
• Machine learning approaches to lung cancer prediction from mass spectra

  2003cited by this paper
• Discriminant models for high‐throughput proteomics mass spectrometer data

  2003cited by this paper
• Disease proteomics

  2003cited by this paper
• Expression Profiling of Breast Cancer Cells by Differential Peptide Display

  2003cited by this paper
• Analysis of human serum proteins by liquid phase isoelectric focusing and matrix‐assisted laser desorption/ionization‐mass spectrometry

  2003cited by this paper
• Therapeutic potential of the plasma proteome.

  2003cited by this paper
• A comprehensive approach to the analysis of matrix‐assisted laser desorption/ionization‐time of flight proteomics spectra from serum samples

  2003cited by this paper
• Tree‐based disease classification using protein data

  2003cited by this paper
• A prototype methodology combining surface‐enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditions

  2003cited by this paper
• Megavariate data analysis of mass spectrometric proteomics data using latent variable projection method

  2003cited by this paper
• Protocols for disease classification from mass spectrometry data

  2003cited by this paper
• Clustering mass spectrometry data using order statistics

  2003cited by this paper
• Multiple approaches to data‐mining of proteomic data based on statistical and pattern classification methods

  2003cited by this paper
• Identification and validation of a potential lung cancer serum biomarker detected by matrix‐assisted laser desorption/ionization‐time of flight spectra analysis

  2003cited by this paper
• Clinical proteomics: are we there yet?

  2003cited by this paper
• Clinical proteomics: translating benchside promise into bedside reality

  2002cited by this paper
• High-resolution peptide mapping of cerebrospinal fluid: a novel concept for diagnosis and research in central nervous system diseases.

  2002cited by this paper
• The Human Plasma Proteome

  2002cited by this paper
• Peptidomics technologies for human body fluids.

  2001cited by this paper
• Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies.

  2001cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• Proteomics: applications in basic and applied biology.

  2000cited by this paper
• The Subtilisin/Kexin Family of Precursor Convertases: Emphasis on PC1, PC2/7B2, POMC and the Novel Enzyme SKI‐1

  1999cited by this paper
• The body as a manufacturer of endostatin

  1999cited by this paper
• Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

  1997cited by this paper
• Matrix-assisted laser desorption/ionisation mass spectrometry guided purification of human guanylin from blood ultrafiltrate.

  1997cited by this paper
• Matrix-assisted laser desorption ionization MS: a progress report.

  1996cited by this paper
• Islet amyloid polypeptide/amylin contents in pancreas change with increasing age in genetically obese and diabetic mice.

  1996cited by this paper
• Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth.

  1994cited by this paper

• Clinical Peptidomics: Advances in Instrumentation, Analyses, and Applications

  2023cites this paper
• Peptidomics analysis of human blood specimens for biomarker discovery

  2007cites this paper